spacer
home > ebr > summer 2002 > technology appraisal process and presents the facts behind the nice appraisal of beta-interferon
PUBLICATIONS
European Biopharmaceutical Review

Technology Appraisal Process and presents the facts behind the NICE appraisal of beta-interferon

The National Institute for Clinical Excellence (NICE or the Institute) is part of the NHS. It provides guidance for the NHS, its patients and their carers about treatment and health care. The guidance on beta-interferon and glatiramer acetate was a part of the technology appraisals work programme. Appraisals are independent considerations of both the clinical and cost effectiveness of health technologies. Topics include medicines, medical devices, diagnostic techniques, surgical procedures and health promotion activities. The Secretary of State for Health and the Welsh Assembly Government decide which topics NICE will appraise. However, once the technology has been referred to NICE, the development of the guidance is the responsibility of NICE alone.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Anne-Toni Rodgers, Communications Director of the National Institute for Clinical Excellence (NICE)

Anne-Toni Rodgers is a pharmacology graduate with a strong track record in communications with the NHS, industry and patients. Prior to joining the Institute, she spent 18 years in a variety of roles for the pharmaceutical industry including pure research, regulatory affairs, sales and marketing and government and industry affairs.
She is a graduate of the Common Purpose Programme, Vice-Chair of the London region of the Institute for Health Service Management, an editorial board member for the Journal of Quality in Healthcare and an advisory board member for the Association of Quality in Healthcare. Anne-Toni acts as an executive lead on both technology appraisals and clinical guidelines, and is a member of the management board of the National Prescribing Centre. She holds responsibility for the communication and dissemination of the Institute's work to all stakeholders. Anne-Toni joined the National Institute for Clinical Excellence on 12th July 1999.

spacer
Anne-Toni Rodgers
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PCI Pharma Services Announces Organization Updates

Philadelphia, PA – May 20, 2019 – PCI Pharma Services, a leading biopharmaceutical outsourcing services provider, is pleased to announce the following management updates to help drive the company’s future vision, strategy and growth.
More info >>

White Papers

Considerations for Choosing the Right Wearable Drug Delivery System

West Pharmaceutical Services, Inc.

For patients with chronic conditions, the use of injectable biologic therapies is on the rise. Biologics, while providing considerable therapeutic benefit, can also present several challenges for both drug manufacturers and patients. In particular, many biologics are highly viscous and others require large doses to be injected slowly over time. This can make it difficult to deliver a consistent dose every time, potentially impacting medication adherence.
More info >>

 
Industry Events

CPhI Korea

21-23 August 2019, COEX, Seoul, South Korea

CPhI Korea provides a dynamic meeting place for a wide range of industry suppliers to engage with purchasers and decision makers from the pharmaceutical industry in Korea and the surrounding region. The exhibition showcases the whole pharma supply chain from ingredients, contracting services to machinery and biopharmaceuticals. It also hosts an extensive conference programme covering the latest trends and topics within the regional market.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement